Contact Lenses Price  
Contact Lenses Search:
Contact Lenses Contact Lens Rebates All discount contacts Add to Favorites Contact Lenses Forum  
Product Type
1-2 Week Disposable
Bifocal Contact Lenses
Color Contact Lenses
Daily Disposable
Monthly Disposable
Rigid Gas Permeables
Toric Contact Lenses
Vial Contact Lenses
Special Effects Contacts
Eye Drops
Contact Lens Cases
Accessories
 
Manufacturers
Bausch & Lomb
CIBA Vision
Coopervision
Johnson & Johnson
Ocular Sciences
Wesley-Jessen
Biocompatibles
Boston
Independent labs
LifeStyle Company
Paragon Vision Sciences
Soft Lens Technology
CL Tinters
OSI/American Hydron
RGP
Sunsoft
Crystal Reflections
Metro Optics
Ocuease
Optech
Unilens
Westcon
AquaSoft
Pharma Lens
Unknown
Benz Research

Ocular Sciences

 

Since Ocular Sciences was incorporated in 1985, its strategy has been to market high quality soft contact lenses to eye care professionals at competitive prices using a low cost to serve operating structure. The company sells products marketed for reusable and disposable wearing regimens. The company sells its products exclusively to eye care professionals because soft contact lenses are medical devices and as such the company believes wearers should return to their original prescribing eye care professional for on going follow up care.

Ocular Sciences' corporate headquarters are located in Concord, California. The Company has approximately 4,000 employees worldwide.

Go to Ocular Sciences website


Please choose the following products of Ocular Sciences

Aqualens 55 Aqualens 55
Biomedics 38 Biomedics 38
Biomedics 55 Biomedics 55
Biomedics 55 Premier - Ultraflex 55 Premier Biomedics 55 Premier - Ultraflex 55 Premier
Biomedics Colors 6 Pk Biomedics Colors 6 Pk
Biomedics One Day 90 Pack Biomedics One Day 90 Pack
Biomedics Toric(UltraFlex Toric) Biomedics Toric(UltraFlex Toric)
Cover Girl Colors (Optimedics / Biomedics Color) Cover Girl Colors (Optimedics / Biomedics Color)
ECHELON BIFOCAL ECHELON BIFOCAL
Edge III 55 Edge III 55
Page:1 2 3 

Today's News about Ocular Sciences


Newly approved ocular safety methods reduce animal testing (EurekAlert!)
Federal regulatory agencies have accepted recommendations of the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) for two methods that can reduce live animal use for ocular safety testing, the committee announced today.

Newly Approved Ocular Safety Methods Reduce Animal Testing (Newswise)
Federal regulatory agencies have accepted recommendations of the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) for two methods that can reduce live animal use for ocular safety testing, the committee announced today. ICCVAM is a permanent interagency committee composed of representatives from 15 federal regulatory and research agencies, including the ...

Market graduates from Loyola (New Orleans Times-Picayune)
The Crescent City Farmers Market, which started in 1995 as an offshoot of Loyola University, will enter a new phase Aug. 1 as an independent nonprofit organization.

Sirion Therapeutics Announces FDA Approval Of Durezol(TM) For Treatment Of Postoperative Ocular Inflammation And Pain (Medical News Today)
Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved its new drug application for Durezol(TM) (difluprednate ophthalmic emulsion) 0.05%, a topical steroid for the treatment of postoperative ocular inflammation and pain. The approval came after a six month priority review.

Sirion Therapeutics Announces FDA Approval of Durezol(TM) for Treatment of Postoperative Ocular Inflammation and Pain (PR Newswire via Yahoo! Finance)
Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that the U.S. Food and Drug Administration has approved its new drug application for Durezol 0.05%, a topical steroid for the treatment of postoperative ocular inflammation and pain.

Alimera Reports Results From The Three-Month Interim Readout Of The Human PK Medidur(TM) FA Study (Medical News Today)
Alimera Sciences, Inc.

The heart and the drive (The Jewish Journal of Greater Los Angeles)
Hatschek Bela. The very sound of my great-grandfather's name brings a smile to my face.

Alimera reports positive interim results from Phase II macular edema trial (Pharmaceutical Business Review)
Alimera Sciences has reported the safety and efficacy results from the first human pharmacokinetic study of Medidur FA, which it intends to market under the tradename Iluvien, if approved by the FDA.

Newly Approved Ocular Safety Methods Reduce Animal Testing (Medical News Today)
Federal regulatory agencies have accepted recommendations of the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) for two methods that can reduce live animal use for ocular safety testing, the committee announced.

pSivida Announces Interim Results From The Three-Month Readout Of The Human PK MedidurTM FA Study (Medical News Today)
Global drug delivery company, pSivida Corp. (NASDAQ: PSDV)(ASX: PVA)(FSE: PSI) today reported the interim three-month safety and efficacy results from the first human pharmacokinetic(1) (PK) study of Medidurâ„¢ FA, in patients with Diabetic Macular Edema (DME). This Phase II study is designed to support the ongoing pivotal Phase III clinical trial of Medidur in DME.
 
Contact Us Resources
© 2004 ContactLensesPrice.com All rights reserved.
Acuvue 2|| Acuvue Advance|| Acuvue Toric|| FreshLook Colorblends|| FreshLook Colors|| Freshlook Dimensions|| Freshlook Radiance|| Optima FW|| Cibasoft Visitint|| Encore Toric|| Frequency 55 Toric|| Optima Toric|| Preference Toric|| Occasions Multifocal|| SofLens Multi-Focal|| Precision UV|| Soflens 66|| Freshlook Enhancers|| Vantage Accent|| Focus Dailies Toric 30 Pk|| Paragon HDS|| Sunflex|| Silsoft